Suppr超能文献

智能杂化材料,配备治疗药物纳米储库。

Smart hybrid materials equipped by nanoreservoirs of therapeutics.

机构信息

Institut National de la Santé et de la Recherche Médicale (INSERM), Unité 977, 11 rue Humann, 67085 Strasbourg, France.

出版信息

ACS Nano. 2012 Jan 24;6(1):483-90. doi: 10.1021/nn203817t. Epub 2011 Dec 23.

Abstract

Nanobiotechnology enables the emergence of entirely new classes of bioactive devices intended for targeted intracellular delivery for more efficacies and less toxicities. Among organic and inorganic approaches currently developed, controlled release from polymer matrices promises utmost clinical impact. Here, a unique nanotechnology strategy is used to entrap, protect, and stabilize therapeutic agents into polymer coatings acting as nanoreservoirs enrobing nanofibers of implantable membranes. Upon contact with cells, therapeutic agents become available through enzymatic degradation of the nanoreservoirs. As cells grow, divide, and infiltrate deeper into the porous membrane, they trigger slow and progressive release of therapeutic agents that, in turn, stimulate further cell proliferation. This constitutes the first instance of a smart living nanostructured hybrid membrane for regenerative medicine. The cell contact-dependent bioerodable nanoreservoirs described here will permit sustained release of drugs, genes, growth factors, etc., opening a general route to the design of sophisticated cell-therapy implants capable of robust and durable regeneration of a broad variety of tissues.

摘要

纳米生物技术使具有全新生物活性的设备得以出现,这些设备旨在进行靶向细胞内递药,以提高疗效和降低毒性。在目前开发的有机和无机方法中,聚合物基质的控制释放具有最大的临床影响。在这里,采用独特的纳米技术策略将治疗剂包埋、保护和稳定在聚合物涂层中,这些聚合物涂层作为纳米储库,包被可植入膜的纳米纤维。与细胞接触后,治疗剂可通过纳米储库的酶降解而获得。随着细胞的生长、分裂和更深地渗透到多孔膜中,它们会触发治疗剂的缓慢和渐进释放,进而刺激进一步的细胞增殖。这是再生医学中智能活体纳米结构杂化膜的第一个实例。这里描述的细胞接触依赖性生物可蚀纳米储库将允许药物、基因、生长因子等的持续释放,为设计能够对各种组织进行强大且持久再生的复杂细胞治疗植入物开辟了一条通用途径。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验